| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1243595A1 Bh4-fused polypeptides |
| 09/25/2002 | EP1243276A1 Elongated and multiple spacers containing activatible prodrugs |
| 09/25/2002 | EP1242825A2 Extraction of biological components from body fluids |
| 09/25/2002 | EP1242617A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 09/25/2002 | EP1242610A1 Method for extractive refolding of scrambledsingle-chain polypeptides |
| 09/25/2002 | EP1242606A2 Schizophrenia associated gene, proteins and biallelic markers |
| 09/25/2002 | EP1242603A2 Vectors and method for producing recombinant proteins in fungi |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242598A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 09/25/2002 | EP1242597A1 Mutated bmp1b receptor as regulator of ovulation rate |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242580A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242457A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242455A1 N-alkylated peptides having antiangiogenic activity |
| 09/25/2002 | EP1242454A2 G protein-coupled receptors |
| 09/25/2002 | EP1242453A1 Dna encoding snorf62 and snorf72 receptors |
| 09/25/2002 | EP1242452A2 Chimeric natriuretic peptides |
| 09/25/2002 | EP1242450A2 Organ transplant rejection and associated conditions |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242448A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/25/2002 | EP1242447A1 Compounds and use thereof to modify transport across cell membranes |
| 09/25/2002 | EP1242446A1 Immunoenzymatic quantification method |
| 09/25/2002 | EP1242443A1 Novel nucleic acids and polypeptides |
| 09/25/2002 | EP1242441A2 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef |
| 09/25/2002 | EP1242157A1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 09/25/2002 | EP1242124A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 09/25/2002 | EP1242122A2 Delivery of proteins across polar epithelial cell layers |
| 09/25/2002 | EP1242116A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 09/25/2002 | EP1242108A1 Optimized minigenes and peptides encoded thereby |
| 09/25/2002 | EP1242107A1 Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1242049A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 09/25/2002 | EP1241934A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241933A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241932A1 Animal models for cardiac disease |
| 09/25/2002 | EP1146897B1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
| 09/25/2002 | EP1115852A4 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 09/25/2002 | EP1093359B1 Method for preparing fibrillin from cnidaria, and resulting compositions useful in cosmetics |
| 09/25/2002 | EP1060184A4 Best's macular dystrophy gene |
| 09/25/2002 | EP1049800A4 Asthma related genes |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0960124A4 Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator |
| 09/25/2002 | EP0845981B1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 09/25/2002 | EP0806958A4 Inhibition of platelet binding |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | EP0652966B1 Method of increasing expression of viral proteins |
| 09/25/2002 | CN1371424A Activatable recombinant neurotoxins |
| 09/25/2002 | CN1371415A Fabrication of beta-pleated sheet proteins with specific binding properties |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1371289A Gene therapy using TGF-beta |
| 09/25/2002 | CN1371243A Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 09/25/2002 | CN1370843A Functions of Tob gene in central nervous system of mammol and its application |
| 09/25/2002 | CN1370783A Small molecular lung cancer antibody targeted immunotoxin and its prepn and use |
| 09/25/2002 | CN1370782A Recombinant syphilis spirochete epitope antigen and multiple-epitope chimeric antigen |
| 09/24/2002 | US6455755 Leukotriene B4 receptor transgenic mice |
| 09/24/2002 | US6455754 Screening for modulators of neuronal receptor binding activity; obtain animal model, incubate with modulator, monitor adjustments in neuronal activity |
| 09/24/2002 | US6455687 Human lactoferrin |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455685 Detecting modulators of immune response; obtain nucleotide sequences, incubate with modulator, remove unbound modulator, detect bound complexes |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455681 DNA molecules encoding single strand gap response proteins involved in activation of a DNA repair/cell cycle checkpoint pathway |
| 09/24/2002 | US6455678 Human hematopoietic stem and progenitor cell antigen |
| 09/24/2002 | US6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455672 Nucleotide sequences which code protein associated with cell proliferation; for use in evaluating root and stem propagation in plants |
| 09/24/2002 | US6455670 Peptide for use in the treatment and prevention of viral diseases |
| 09/24/2002 | US6455668 Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 09/24/2002 | US6455509 Dengue nucleic acid vaccines that induce neutralizing antibodies |
| 09/24/2002 | US6455503 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/24/2002 | US6455498 Structural alterations of the EGF receptor genes in human tumors |
| 09/24/2002 | US6455496 NL2 TIE ligand homologue polypeptide |
| 09/24/2002 | US6455494 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 09/24/2002 | US6455493 Methods for using heat shock proteins |
| 09/24/2002 | US6455492 Hepatitis E virus vaccine and method |
| 09/24/2002 | US6455323 Contacting virulence protein with chemical compound, then identifying compounds which bind or interacts with protein; for bactericides against staphylococcus aureus |
| 09/24/2002 | US6455314 Recombinant fiber protein having a trimerization domain and which interacts with adenoviral penton base; for gene transfer methods |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455300 Mammalian cell with steroid receptor response elements; for screening agonists and antagonists |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455281 Nucleic acids for identifying anti-fungal agents, and uses related thereto |
| 09/24/2002 | US6455280 Amino acid sequence of polypeptide involved in apoptosis; anticarcinogenic agents; antitumor agents |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455276 Human α4 receptor subunit of the GABA-A receptor |
| 09/24/2002 | US6455266 Receptor for a Bacillus thuringiensis toxin |
| 09/24/2002 | US6455265 Preparing candidate immunogenic agents based on an envelope protein of a pathogenic strain, then selecting a modified polypeptide which induces an immune response against the immunodomnant region of the protein but not the host |
| 09/24/2002 | US6455262 Receptor polypeptides and their production and uses |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455252 Determination of Genetic sex in equine species by analysis of y-chromosomal DNA sequences |
| 09/24/2002 | US6455251 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 09/24/2002 | US6455248 Reagents and kits for detecting fungal pathogens in a biological sample |
| 09/24/2002 | US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes |
| 09/24/2002 | US6455245 For immunoassay detection |